世界の大発作市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Grand Mal Seizure Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2625 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、大発作のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他）、用途別市場規模（病院、クリニック、学術・研究センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・大発作の市場動向 ・企業の競争状況、市場シェア ・大発作の種類別市場規模（バルビツール酸塩、ヒダントイン、フェニルトリアジン、イミノスチルベン、ベンゾジアゼピン、脂肪族カルボン酸、その他） ・大発作の用途別市場規模（病院、クリニック、学術・研究センター、その他） ・大発作の北米市場規模2016-2027（アメリカ、カナダ） ・大発作のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・大発作のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・大発作の中南米市場規模2016-2027（メキシコ、ブラジル） ・大発作の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Johnson & Johnson、UCB Celltech、Abbott Laboratories、GlaxoSmithKline、Novartis、Sanofi、Takeda、Teva Pharmaceutical） ・結論

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.

Market Analysis and Insights: Global Grand Mal Seizure Market
The global Grand Mal Seizure market size is projected to reach US$ 23500 million by 2026, from US$ 19890 million in 2019, at a CAGR of 2.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Grand Mal Seizure market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Grand Mal Seizure market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Grand Mal Seizure market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Grand Mal Seizure market.

Global Grand Mal Seizure Scope and Market Size
Grand Mal Seizure market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Grand Mal Seizure market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acid
Others

Segment by Application
Hospitals
Clinics
Academic and Research Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Johnson & Johnson
UCB Celltech
Abbott Laboratories
GlaxoSmithKline
Novartis
Sanofi
Takeda
Teva Pharmaceutical

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Grand Mal Seizure Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Barbiturates
1.2.3 Hydantoin
1.2.4 Phenyltriazine
1.2.5 Iminostilbenes
1.2.6 Benzodiazepines
1.2.7 Aliphatic Carboxylic Acid
1.2.8 Others
1.3 Market by Application
1.3.1 Global Grand Mal Seizure Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Academic and Research Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Grand Mal Seizure Market Perspective (2016-2027)
2.2 Grand Mal Seizure Growth Trends by Regions
2.2.1 Grand Mal Seizure Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Grand Mal Seizure Historic Market Share by Regions (2016-2021)
2.2.3 Grand Mal Seizure Forecasted Market Size by Regions (2022-2027)
2.3 Grand Mal Seizure Industry Dynamic
2.3.1 Grand Mal Seizure Market Trends
2.3.2 Grand Mal Seizure Market Drivers
2.3.3 Grand Mal Seizure Market Challenges
2.3.4 Grand Mal Seizure Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Grand Mal Seizure Players by Revenue
3.1.1 Global Top Grand Mal Seizure Players by Revenue (2016-2021)
3.1.2 Global Grand Mal Seizure Revenue Market Share by Players (2016-2021)
3.2 Global Grand Mal Seizure Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Grand Mal Seizure Revenue
3.4 Global Grand Mal Seizure Market Concentration Ratio
3.4.1 Global Grand Mal Seizure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Grand Mal Seizure Revenue in 2020
3.5 Grand Mal Seizure Key Players Head office and Area Served
3.6 Key Players Grand Mal Seizure Product Solution and Service
3.7 Date of Enter into Grand Mal Seizure Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Grand Mal Seizure Breakdown Data by Type
4.1 Global Grand Mal Seizure Historic Market Size by Type (2016-2021)
4.2 Global Grand Mal Seizure Forecasted Market Size by Type (2022-2027)

5 Grand Mal Seizure Breakdown Data by Application
5.1 Global Grand Mal Seizure Historic Market Size by Application (2016-2021)
5.2 Global Grand Mal Seizure Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Grand Mal Seizure Market Size (2016-2027)
6.2 North America Grand Mal Seizure Market Size by Type
6.2.1 North America Grand Mal Seizure Market Size by Type (2016-2021)
6.2.2 North America Grand Mal Seizure Market Size by Type (2022-2027)
6.2.3 North America Grand Mal Seizure Market Size by Type (2016-2027)
6.3 North America Grand Mal Seizure Market Size by Application
6.3.1 North America Grand Mal Seizure Market Size by Application (2016-2021)
6.3.2 North America Grand Mal Seizure Market Size by Application (2022-2027)
6.3.3 North America Grand Mal Seizure Market Size by Application (2016-2027)
6.4 North America Grand Mal Seizure Market Size by Country
6.4.1 North America Grand Mal Seizure Market Size by Country (2016-2021)
6.4.2 North America Grand Mal Seizure Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Grand Mal Seizure Market Size (2016-2027)
7.2 Europe Grand Mal Seizure Market Size by Type
7.2.1 Europe Grand Mal Seizure Market Size by Type (2016-2021)
7.2.2 Europe Grand Mal Seizure Market Size by Type (2022-2027)
7.2.3 Europe Grand Mal Seizure Market Size by Type (2016-2027)
7.3 Europe Grand Mal Seizure Market Size by Application
7.3.1 Europe Grand Mal Seizure Market Size by Application (2016-2021)
7.3.2 Europe Grand Mal Seizure Market Size by Application (2022-2027)
7.3.3 Europe Grand Mal Seizure Market Size by Application (2016-2027)
7.4 Europe Grand Mal Seizure Market Size by Country
7.4.1 Europe Grand Mal Seizure Market Size by Country (2016-2021)
7.4.2 Europe Grand Mal Seizure Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Grand Mal Seizure Market Size (2016-2027)
8.2 Asia-Pacific Grand Mal Seizure Market Size by Type
8.2.1 Asia-Pacific Grand Mal Seizure Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Grand Mal Seizure Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Grand Mal Seizure Market Size by Type (2016-2027)
8.3 Asia-Pacific Grand Mal Seizure Market Size by Application
8.3.1 Asia-Pacific Grand Mal Seizure Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Grand Mal Seizure Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Grand Mal Seizure Market Size by Application (2016-2027)
8.4 Asia-Pacific Grand Mal Seizure Market Size by Region
8.4.1 Asia-Pacific Grand Mal Seizure Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Grand Mal Seizure Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Grand Mal Seizure Market Size (2016-2027)
9.2 Latin America Grand Mal Seizure Market Size by Type
9.2.1 Latin America Grand Mal Seizure Market Size by Type (2016-2021)
9.2.2 Latin America Grand Mal Seizure Market Size by Type (2022-2027)
9.2.3 Latin America Grand Mal Seizure Market Size by Type (2016-2027)
9.3 Latin America Grand Mal Seizure Market Size by Application
9.3.1 Latin America Grand Mal Seizure Market Size by Application (2016-2021)
9.3.2 Latin America Grand Mal Seizure Market Size by Application (2022-2027)
9.3.3 Latin America Grand Mal Seizure Market Size by Application (2016-2027)
9.4 Latin America Grand Mal Seizure Market Size by Country
9.4.1 Latin America Grand Mal Seizure Market Size by Country (2016-2021)
9.4.2 Latin America Grand Mal Seizure Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Grand Mal Seizure Market Size (2016-2027)
10.2 Middle East & Africa Grand Mal Seizure Market Size by Type
10.2.1 Middle East & Africa Grand Mal Seizure Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Grand Mal Seizure Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Grand Mal Seizure Market Size by Type (2016-2027)
10.3 Middle East & Africa Grand Mal Seizure Market Size by Application
10.3.1 Middle East & Africa Grand Mal Seizure Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Grand Mal Seizure Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Grand Mal Seizure Market Size by Application (2016-2027)
10.4 Middle East & Africa Grand Mal Seizure Market Size by Country
10.4.1 Middle East & Africa Grand Mal Seizure Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Grand Mal Seizure Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Grand Mal Seizure Introduction
11.1.4 Pfizer Revenue in Grand Mal Seizure Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Grand Mal Seizure Introduction
11.2.4 Johnson & Johnson Revenue in Grand Mal Seizure Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 UCB Celltech
11.3.1 UCB Celltech Company Details
11.3.2 UCB Celltech Business Overview
11.3.3 UCB Celltech Grand Mal Seizure Introduction
11.3.4 UCB Celltech Revenue in Grand Mal Seizure Business (2016-2021)
11.3.5 UCB Celltech Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Grand Mal Seizure Introduction
11.4.4 Abbott Laboratories Revenue in Grand Mal Seizure Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Grand Mal Seizure Introduction
11.5.4 GlaxoSmithKline Revenue in Grand Mal Seizure Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Grand Mal Seizure Introduction
11.6.4 Novartis Revenue in Grand Mal Seizure Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Grand Mal Seizure Introduction
11.7.4 Sanofi Revenue in Grand Mal Seizure Business (2016-2021)
11.7.5 Sanofi Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Grand Mal Seizure Introduction
11.8.4 Takeda Revenue in Grand Mal Seizure Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Teva Pharmaceutical
11.9.1 Teva Pharmaceutical Company Details
11.9.2 Teva Pharmaceutical Business Overview
11.9.3 Teva Pharmaceutical Grand Mal Seizure Introduction
11.9.4 Teva Pharmaceutical Revenue in Grand Mal Seizure Business (2016-2021)
11.9.5 Teva Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Grand Mal Seizure Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Barbiturates
Table 3. Key Players of Hydantoin
Table 4. Key Players of Phenyltriazine
Table 5. Key Players of Iminostilbenes
Table 6. Key Players of Benzodiazepines
Table 7. Key Players of Aliphatic Carboxylic Acid
Table 8. Key Players of Others
Table 9. Global Grand Mal Seizure Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Grand Mal Seizure Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Grand Mal Seizure Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Grand Mal Seizure Market Share by Regions (2016-2021)
Table 13. Global Grand Mal Seizure Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Grand Mal Seizure Market Share by Regions (2022-2027)
Table 15. Grand Mal Seizure Market Trends
Table 16. Grand Mal Seizure Market Drivers
Table 17. Grand Mal Seizure Market Challenges
Table 18. Grand Mal Seizure Market Restraints
Table 19. Global Grand Mal Seizure Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Grand Mal Seizure Market Share by Players (2016-2021)
Table 21. Global Top Grand Mal Seizure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Grand Mal Seizure as of 2020)
Table 22. Ranking of Global Top Grand Mal Seizure Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Grand Mal Seizure Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Grand Mal Seizure Product Solution and Service
Table 26. Date of Enter into Grand Mal Seizure Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Grand Mal Seizure Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Grand Mal Seizure Revenue Market Share by Type (2016-2021)
Table 30. Global Grand Mal Seizure Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Grand Mal Seizure Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Grand Mal Seizure Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Grand Mal Seizure Revenue Market Share by Application (2016-2021)
Table 34. Global Grand Mal Seizure Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Grand Mal Seizure Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Grand Mal Seizure Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Grand Mal Seizure Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Grand Mal Seizure Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Grand Mal Seizure Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Grand Mal Seizure Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Grand Mal Seizure Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Grand Mal Seizure Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Grand Mal Seizure Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Grand Mal Seizure Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Grand Mal Seizure Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Grand Mal Seizure Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Grand Mal Seizure Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Grand Mal Seizure Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Grand Mal Seizure Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Grand Mal Seizure Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Grand Mal Seizure Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Grand Mal Seizure Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Grand Mal Seizure Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Grand Mal Seizure Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Grand Mal Seizure Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Grand Mal Seizure Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Grand Mal Seizure Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Grand Mal Seizure Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Grand Mal Seizure Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Grand Mal Seizure Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Grand Mal Seizure Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Grand Mal Seizure Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Grand Mal Seizure Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Grand Mal Seizure Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Grand Mal Seizure Market Size by Country (2022-2027) & (US$ Million)
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Grand Mal Seizure Product
Table 69. Pfizer Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Grand Mal Seizure Product
Table 74. Johnson & Johnson Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. UCB Celltech Company Details
Table 77. UCB Celltech Business Overview
Table 78. UCB Celltech Grand Mal Seizure Product
Table 79. UCB Celltech Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 80. UCB Celltech Recent Development
Table 81. Abbott Laboratories Company Details
Table 82. Abbott Laboratories Business Overview
Table 83. Abbott Laboratories Grand Mal Seizure Product
Table 84. Abbott Laboratories Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 85. Abbott Laboratories Recent Development
Table 86. GlaxoSmithKline Company Details
Table 87. GlaxoSmithKline Business Overview
Table 88. GlaxoSmithKline Grand Mal Seizure Product
Table 89. GlaxoSmithKline Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 90. GlaxoSmithKline Recent Development
Table 91. Novartis Company Details
Table 92. Novartis Business Overview
Table 93. Novartis Grand Mal Seizure Product
Table 94. Novartis Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 95. Novartis Recent Development
Table 96. Sanofi Company Details
Table 97. Sanofi Business Overview
Table 98. Sanofi Grand Mal Seizure Product
Table 99. Sanofi Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 100. Sanofi Recent Development
Table 101. Takeda Company Details
Table 102. Takeda Business Overview
Table 103. Takeda Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 104. Takeda Recent Development
Table 105. Teva Pharmaceutical Company Details
Table 106. Teva Pharmaceutical Business Overview
Table 107. Teva Pharmaceutical Grand Mal Seizure Product
Table 108. Teva Pharmaceutical Revenue in Grand Mal Seizure Business (2016-2021) & (US$ Million)
Table 109. Teva Pharmaceutical Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Grand Mal Seizure Market Share by Type: 2020 VS 2027
Figure 2. Barbiturates Features
Figure 3. Hydantoin Features
Figure 4. Phenyltriazine Features
Figure 5. Iminostilbenes Features
Figure 6. Benzodiazepines Features
Figure 7. Aliphatic Carboxylic Acid Features
Figure 8. Others Features
Figure 9. Global Grand Mal Seizure Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Academic and Research Centers Case Studies
Figure 13. Others Case Studies
Figure 14. Grand Mal Seizure Report Years Considered
Figure 15. Global Grand Mal Seizure Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Grand Mal Seizure Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Grand Mal Seizure Market Share by Regions: 2020 VS 2027
Figure 18. Global Grand Mal Seizure Market Share by Regions (2022-2027)
Figure 19. Global Grand Mal Seizure Market Share by Players in 2020
Figure 20. Global Top Grand Mal Seizure Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Grand Mal Seizure as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Grand Mal Seizure Revenue in 2020
Figure 22. Global Grand Mal Seizure Revenue Market Share by Type (2016-2021)
Figure 23. Global Grand Mal Seizure Revenue Market Share by Type (2022-2027)
Figure 24. North America Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Grand Mal Seizure Market Share by Type (2016-2027)
Figure 26. North America Grand Mal Seizure Market Share by Application (2016-2027)
Figure 27. North America Grand Mal Seizure Market Share by Country (2016-2027)
Figure 28. United States Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Grand Mal Seizure Market Share by Type (2016-2027)
Figure 32. Europe Grand Mal Seizure Market Share by Application (2016-2027)
Figure 33. Europe Grand Mal Seizure Market Share by Country (2016-2027)
Figure 34. Germany Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Grand Mal Seizure Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Grand Mal Seizure Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Grand Mal Seizure Market Share by Region (2016-2027)
Figure 44. China Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Grand Mal Seizure Market Share by Type (2016-2027)
Figure 52. Latin America Grand Mal Seizure Market Share by Application (2016-2027)
Figure 53. Latin America Grand Mal Seizure Market Share by Country (2016-2027)
Figure 54. Mexico Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Grand Mal Seizure Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Grand Mal Seizure Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Grand Mal Seizure Market Share by Country (2016-2027)
Figure 60. Turkey Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Grand Mal Seizure Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Pfizer Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 64. Johnson & Johnson Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 65. UCB Celltech Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 66. Abbott Laboratories Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 69. Sanofi Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 70. Takeda Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 71. Teva Pharmaceutical Revenue Growth Rate in Grand Mal Seizure Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

---